Page last updated: 2024-08-23

bezafibrate and 8-epi-prostaglandin f2alpha

bezafibrate has been researched along with 8-epi-prostaglandin f2alpha in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buytenhek, R; de Man, FH; Jonkers, IJ; Leuven, JA; Onkenhout, W; Princen, HM; Schwedhelm, E; Smelt, AH; Troost, R; van Der Laarse, A; van Duyvenvoorde, W	1

Trials

1 trial(s) available for bezafibrate and 8-epi-prostaglandin f2alpha

Article	Year
Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy. Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:11 Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dinoprost; Double-Blind Method; Female; Humans; Hypertriglyceridemia; In Vitro Techniques; Lipid Metabolism; Lipids; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress	2000

Article

Year

Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.

Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:11

Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dinoprost; Double-Blind Method; Female; Humans; Hypertriglyceridemia; In Vitro Techniques; Lipid Metabolism; Lipids; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress

2000